We felt his femoral and popliteal pulses, but could not feel the dorsalis pedis and posterior tibial pulses bilaterally. We observed no sicca, telangiectasias, calcinosis, sclerodactyly, rash, livedo, ...
Avelumab is under clinical development by Merck and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition success rate ...